Fig. 1

Economic impact (cost items), excluding the related costs for HCV therapy, in HIV+ and HIV/HCV populations, with one comorbidity
Economic impact (cost items), excluding the related costs for HCV therapy, in HIV+ and HIV/HCV populations, with one comorbidity